Walsby EJ, Coles SJ, Knapper S, Burnett AK. The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine. Haematologica [Internet]. 2011Feb.28 [cited 2026Nov.10];96(3):393-9. Available from: https://haematologica.org/article/view/5901